Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Bacteria-mucin interactions – Shaping intestinal epithelial responses in health and disease

Project description

Intestinal mucins and epithelial responses to bacteria

Human gut microbiota are the microorganisms of the digestive tract. Some represent a beneficial commensal bacteria but others could be pathobionts that cause inflammation. The intestinal mucus layer defines how specific microbiota members affect health and disease. The mucus layer has soluble mucins and epithelial transmembrane mucins that regulate host responses; the molecular mechanisms of these interactions are largely unknown. The EU-funded Bac2MUC project aims to identify molecular mechanisms via which distinct bacterial species regulate the functions of transmembrane mucins in the intestine. Earlier studies showed that mucin MUC1 is a key receptor for Salmonella invasion into epithelial cells, and MUC13 is a central regulator of epithelial barrier formation. The current project hypothesis is that bacteria-mucin interactions define epithelial responses by stimulating barrier formation, promoting inflammation or mediating bacterial invasion.

Objective

The intestinal microbiota consists of beneficial commensal bacteria and pathobionts that cause inflammation. The intestinal mucus layer dictates how specific members of the microbiota affect health and disease. The mucus layer consists of soluble mucins and epithelial transmembrane (TM) mucins that regulate host responses. The molecular mechanisms as to how the intestinal microbiota affect the functions of TM mucins is largely unknown. My recent work shows that TM mucin MUC1 is a key receptor for Salmonella invasion into polarized epithelial cells. We also discovered that MUC13 is a central regulator of epithelial barrier formation. I hypothesize that bacteria-mucin interactions shape epithelial responses by stimulating healthy barrier formation, driving inflammation or mediating bacterial invasion. My aim is to unravel molecular mechanisms via which distinct bacterial species regulate the functions of TM mucins MUC1 and MUC13 in the intestine. The key objectives of Bac2MUC are to: 1. Identify commensal and pathogenic bacteria that target TM mucins 2. Elucidate TM mucin signaling pathways activated by commensal and pathogenic bacteria 3. Determine the function of TM mucins during inflammation and invasion 4. Utilize bacteria-TM mucin interactions to unravel healthy epithelial barrier regulation I will use an innovative large-scale screening platform to identify novel bacteria-mucin interactions. TM mucin signaling pathways during bacterial interaction will be characterized by sortase technology. Cutting-edge technologies such as CRISPR/Cas9 genome editing and advanced microscopy will be applied in established bacterial infection assays with intestinal cell lines and organoids. Bac2MUC is an ambitious and ground-breaking project that will address, for the first time, the complex interplay between intestinal bacteria and TM mucins. This project will contribute to clinical strategies that prevent intestinal inflammation and improve mucosal barrier function.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

ERC-STG - Starting Grant

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2019-STG

See all projects funded under this call

Host institution

UNIVERSITEIT UTRECHT
Net EU contribution
€ 1 500 000,00
Address
HEIDELBERGLAAN 8
3584 CS Utrecht
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 500 000,00

Beneficiaries (1)